Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]

What is new for treatment of soft tissue and bone sarcomas?

Dr Silvia Stacchiotti - The National Cancer Institute of Milan, Italy

What is new for treatment of soft tissue and bone sarcomas? ( Dr Silvia Stacchiotti - The National Cancer Institute of Milan, Italy )

Novel therapies and combinations in ovarian cancer

Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France

Novel therapies and combinations in ovarian cancer ( Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France )

What's new on ADCs in management of advanced NSCLC

Dr David Planchard - Institute Gustave Roussy, Villejuif, France

What's new on ADCs in management of advanced NSCLC ( Dr David Planchard - Institute Gustave Roussy, Villejuif, France )

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene...

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )

Personalised systemic treatment in advanced prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France

Personalised systemic treatment in advanced prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France )

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...

Dr Thierry André - Sorbonne Université, Paris, France

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )

T-DM1 shows promise in treating unresectable locally advanced or metastatic...

Dr Sara Hurvitz - University of Washington, Seattle, USA

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer ( Dr Sara Hurvitz - University of Washington, Seattle, USA )

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer

Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma...

Dr Jonathan Friedberg - University of Rochester, Rochester, USA

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy ( Dr Jonathan Friedberg - University of Rochester, Rochester, USA )

Lived experiences of survival following cancer treatments

Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Ituku-Ozalia...

Lived experiences of survival following cancer treatments ( Dr Nwamaka Lasebikan - University of Nigeria Teaching Hospital, Ituku-Ozalia, Nigeria )

The genomics of cancer in Africa

Prof Solomon Rotimi - Covenant University, Ota, Nigeria

The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )

More from ecancer